In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients

G Nesher1, T G Osborn, T L Moore

  • 1Department of Internal Medicine, Saint Louis University Health Sciences Center, Missouri 63104, USA.

Abstract

Insights

Methotrexate (MTX) significantly reduces spermidine and spermine levels in rheumatoid arthritis (RA) lymphocytes, suggesting a key mechanism for its immune-modulating effects. This inhibition is specific and linked to the S-adenosyl-methionine pathway.

Area of Science:

  • Immunology
  • Biochemistry
  • Pharmacology

Background:

  • Elevated polyamine levels are observed in rheumatoid arthritis (RA).
  • Methotrexate (MTX) is a common RA treatment, and its mechanism may involve polyamine synthesis inhibition in lymphocytes.

Purpose of the Study:

  • To investigate the inhibitory effect of MTX on polyamine synthesis in RA lymphocytes.
  • To determine the specificity of MTX's effect on polyamine synthesis.

Main Methods:

  • RA lymphocytes were stimulated and incubated with MTX, hydrocortisone, or D-penicillamine in vitro.
  • Intracellular polyamine levels (spermidine, spermine, putrescine) were measured.
  • Correlation between polyamine levels and IgM-rheumatoid factor (RF) synthesis was analyzed.

Main Results:

  • MTX caused a concentration-dependent decrease in spermidine and spermine levels, but not putrescine.
  • Folinic acid or S-adenosyl-methionine (SAM) reversed the MTX-induced inhibition.
  • Hydrocortisone and D-penicillamine did not significantly affect polyamine levels.
  • A positive correlation was found between polyamine levels and MTX's inhibition of IgM-RF synthesis.

Conclusions:

  • MTX inhibits spermidine and spermine synthesis in RA lymphocytes via the SAM-dependent pathway.
  • This polyamine synthesis inhibition is a potential mechanism for MTX's immune-modulating properties in RA.